Gadolinium-Enhanced Computed Tomography Angiography in Multi-Detector Row Computed Tomography: Initial Observations

Academic Radiology

Volumn 11, Issue 1, 2004, Pages 61-68

  Bae, Kyongtae T ^a   McDermott, Ronan ^a   Gierada, David S ^a   Heiken, Jay P ^a   Nolte, Mark A ^a   Takahashi, Naoki ^a   Hong, Cheng ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aorta; Computed tomography; Contrast media; Gadolinium; Helical technology; Iodine

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM; GADOVERSETAMIDE; IODINATED CONTRAST MEDIUM; IOVERSOL;

ANGIOGRAPHY; ANIMAL EXPERIMENT; AORTA; ARTICLE; BLOOD VESSEL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; LUNG ARTERY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SWINE;

EID: 0346102679     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1076-6332(03)00536-1     Document Type: Article

References (16)

1. Rubin GD, Walker PJ, Dake MD, et al. Three-dimensional spiral computed tomographic angiography: an alternative imaging modality for the abdominal aorta and its branches. J Vasc Surg 1993; 18:656-64discussion 665.
2. Rubin GD, Paik DS, Johnston PC, Napel S. Measurement of the aorta and its branches with helical CT. Radiology 1998; 206:823-829.
3. Goldstein H, Kashanian F, Blumetti R, Holyoak W, Hugo F, Blumenfeld D. Safety assessment of gadopentetate dimeglumine in US clinical trials. Radiology 1990; 174:17-23.
4. Niendorf HP, Haustein J, Louton T, Beck W, Laniado M. Safety and tolerance after intravenous administration of 0.3 mmol/kg GD-DTPA: Results of a randomized, controlled clinical trial. Invest Radiol 1991; 26:S221-S223.
5. Prince MR, Arnoldus C, Frisoli JK. Nephrotoxicity of high-dose gadolinium compared with iodinated lodinated contrast. J Magn Reson Imaging 1996; 6:162-166.
6. Spring DB, Bettmann MA, Barkan HE. Nonfatal adverse reactions to iodinated contrast media: spontaneous reporting to the U.S. Food and Drug Administration, 1978-1994. Radiology 1997; 204:325-332.
7. Spring DB, Bettmann MA, Barkan HE. Deaths related to iodinated contrast media reported spontaneously to the U.S. Food and Drug Administration, 1978-1994: effect of the availability of low-osmolality contrast media. Radiology 1997; 204:333-337.
8. Bloem JL, Wondergem J. Gd-DTPA as a contrast agent in CT. Radiology 1989; 171:578-579.
9. O'Hare NJ. Contrast agent CT imaging in variable sized organs using single energy synchrotron radiation. Phys Med Biol 1992; 37:1519-1530.
10. Quinn AD, O'Hare NJ, Wallis FJ, Wilson GF. Gd-DTPA: an alternative contrast medium for CT. J Comput Assist Tomogr 1994; 18:634-636.
11. Gierada DS, Bae KT. Gadolinium as a CT contrast agent: assessment in a porcine model. Radiology 1999; 210:829-834.
12. Luboldt W, De Santis M, von Smekal A, Reiser M. Attenuation characteristics and application of gadolinium-DTPA in fast helical computed tomography. Invest Radiol 1997; 32:690-695.
13. Bae KT, Heiken JP, Brink JA. Aortic and hepatic contrast medium enhancement at CT: Part II. Effect of reduced cardiac output in a porcine model. Radiology 1998; 207:657-662.
14. Zwicker C, Langer M, Langer R, Keske U. Comparison of iodinated and noniodinated contrast media in computed tomography. Invest Radiol 1991; 26:S162-S164.
15. Han JK, Kim AY, Lee KY, et al. Factors influencing vascular and hepatic enhancement at CT: experimental study on injection protocol using a canine model. J Comput Assist Tomogr 2000; 24:400-406.
16. Thomsen HS, Almen T, Morcos SK. Gadolinium-containing contrast media for radiographic examinations: a position paper. Eur Radiol 2002; 12:2600-2605.